Optima Capital’s Innoviva INVA Stock Holding History

Optima Capital’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28	Closed	-$560	–	710
2025 Q4	$560	Buy	+28	New	+$547	﹤0.01%	1141

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optima Capital's INVA Position: Q1 2026 in Review

Optima Capital sold out of Innoviva (INVA) in Q1 2026, closing a stake of 28 shares — an estimated $560 sold.

Optima Capital first reported a position in INVA in Q4 2025 and held it in 1 quarter. The position peaked at $560 in Q4 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

Optima Capital reported no remaining Innoviva position as of Q1 2026 after selling out during the quarter.
Optima Capital sold 28 Innoviva shares in Q1 2026, an estimated $560.
Optima Capital first reported a position in Innoviva in Q4 2025 and held it in 1 quarter.
Optima Capital's Innoviva position peaked at $560 in Q4 2025.
286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Optima Capital's 13F filing for Q1 2026, filed 5 May 2026.